Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST – MIA(IMP) 11387

Authorisation NumberUK MIA(IMP) 11387
Category
MIA(IMP)
HolderGUY'S AND ST THOMAS' NHS FOUNDATION TRUST
Registered AddressGUY'S AND ST THOMAS' NHS FOUNDATION TRUST, PHARMACY MANUFACTURING UNIT, 13TH FLOOR, GUY'S TOWER, GUY'S HOSPITAL, GREAT MAZE POND, LONDON, SE1 9RT, UNITED KINGDOM
Authorisation DateFeb 03, 2026
Legal BasisInvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031]
Sites4
Manufacturing Operations
1.1
1.1.1
1.1.1.1
1.1.1.4
1.1.1.6
1.1.2
1.1.2.1
1.1.2.2
1.1.2.3
1.1.3
1.2
1.2.1
1.2.1.1
1.2.1.11
1.2.1.13
1.2.1.15
1.2.1.5
1.2.1.6
1.2.2
1.3
1.3.1
1.3.1.3
1.3.1.4
1.3.1.5
1.3.1.6
1.3.1.8
1.3.2
1.3.2.6
1.3.2.8
1.4
1.4.2
1.4.2.1
1.4.2.3
1.5
1.5.1
1.5.1.1
1.5.1.11
1.5.1.13
1.5.1.15
1.5.1.5
1.5.1.6
1.5.2
1.6
1.6.1
1.6.2
1.6.3
1.6.4
Importation Operations
2.2
2.2.3
2.2.3.3
2.2.3.4
MHRA LinkView on MHRA Website

Sites (4)

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.1 — Large volume liquids
1.1.1.4 — Small volume liquids
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.1.8 — Other biological medicinal products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.6 — Quality control testing
1.6.1 — Microbiological: sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.2 — Batch certification of imported medicinal products
2.2.3 — Biological medicinal products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
RADIOPHARMACY UNIT
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.1.6 — Other aseptically prepared products
1.1.3 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.8 — Other biological medicinal products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
GUY'S AND ST THOMAS' NHS FOUNDATION TRUST
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.6 — Liquids for internal use
1.2.1.15 — Other non-sterile medicinal products
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.6 — Human or animal extracted products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.6 — Human or animal extracted products
1.3.2.8 — Other biological medicinal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.6 — Liquids for internal use
1.5.1.15 — Other non-sterile medicinal products
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
GUY'S AND ST THOMAS' NHS FOUNDATION TRUST
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.2 — Terminally Sterilised (processing operations for the following dosage forms)
1.1.2.1 — Large volume liquids
1.1.2.2 — Semi-solids
1.1.2.3 — Small volume liquids
1.1.3 — Batch certification
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.11 — Semi-solids
1.2.1.13 — Tablets
1.2.2 — Batch certification
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.3 — Moist heat
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.11 — Semi-solids
1.5.1.13 — Tablets
1.5.1.15 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical

Content Preview

The source document is available on KeyPedia. Sign in to view.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.